Sexual Dysfunction Among Inflammatory Bowel Disease Adults-Clinical Trial (SexIA-CT)

September 27, 2022 updated by: University Hospital, Bordeaux
Patients with Inflammatory Bowel Disease (IBD) have higher rates of sexual dysfunction than the general population. We offer an educational program on IBD including a specific discussion on intimacy and sexuality for IBD patients. Our objective is to investigate the benefit of this intervention on sexual function in patients with IBD.

Study Overview

Detailed Description

Patients with Inflammatory Bowel Disease (IBD) have higher rates of sexual dysfunction than healthy controls. No interventional study has addressed this matter so far. The aim of our study is to investigative the benefit of a psycho-educational intervention on sexual function in patients with IBD, by comparing patients participating to an educational program including a specific discussion on intimacy and sexuality to patients followed in usual care.

Study Type

Observational

Enrollment (Anticipated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patient with Crohn's disease or Ulcerative Colitis diagnosed according to usual criteria.

Description

Inclusion Criteria:

  • Age > 18 years
  • Crohn's disease or Ulcerative Colitis diagnosed according to usual criteria
  • Participation to IBD educational program

Exclusion Criteria:

  • Unability to read or write French
  • Patients without sexual activity for religious reasons

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients participating in the therapeutic education program
Patients participating in an educational program on Inflammatory Bowel Disease (IBD) including a specific discussion on intimacy and sexuality .

All patients participating in the therapeutic education program will complete a self-administered questionnaire before participation in educational program.

A new identical self-questionnaire will be distributed to patients 3 to 6 months after their participation in the therapeutic education program.

Patients control (not participating in the therapeutic education program)
A control group (at the rate of two controls for one case) will be made up of IBD patients routinely followed in the gastroenterology department.Those patients will not participate in the therapeutic education program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Mean scores of sexual function scores using International Index of Erectile Function (IIEF) for men
Time Frame: before participation to educational program
before participation to educational program
Mean scores of sexual function scores using International Index of Erectile Function (IIEF) for men
Time Frame: from 3 to 6 months after participation to educational program.
from 3 to 6 months after participation to educational program.
Mean scores of sexual function scores using Female Sexual Function Index (FSFI) for women.
Time Frame: before participation to educational program
before participation to educational program
Mean scores of sexual function scores using Female Sexual Function Index (FSFI) for women.
Time Frame: from 3 to 6 months after participation to educational program.
from 3 to 6 months after participation to educational program.

Secondary Outcome Measures

Outcome Measure
Time Frame
Mean scores for quality of life (S-IBDQ)
Time Frame: before participation to educational program
before participation to educational program
Mean scores for quality of life (S-IBDQ)
Time Frame: from 3 to 6 months after participation to educational program.
from 3 to 6 months after participation to educational program.
Mean scores for anxiety and depression (HADS)
Time Frame: before participation to educational program
before participation to educational program
Mean scores for anxiety and depression (HADS)
Time Frame: from 3 to 6 months after participation to educational program.
from 3 to 6 months after participation to educational program.
Mean scores for fatigue (FSS)
Time Frame: before participation to educational program
before participation to educational program
Mean scores for fatigue (FSS)
Time Frame: from 3 to 6 months after participation to educational program.
from 3 to 6 months after participation to educational program.
Means score for body image (BIS).
Time Frame: before participation to educational program
before participation to educational program
Means score for body image (BIS).
Time Frame: from 3 to 6 months after participation to educational program.
from 3 to 6 months after participation to educational program.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 7, 2022

Primary Completion (Anticipated)

September 5, 2023

Study Completion (Anticipated)

September 5, 2023

Study Registration Dates

First Submitted

December 2, 2021

First Submitted That Met QC Criteria

January 27, 2022

First Posted (Actual)

February 9, 2022

Study Record Updates

Last Update Posted (Actual)

September 28, 2022

Last Update Submitted That Met QC Criteria

September 27, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammatory Bowel Diseases

Clinical Trials on self-administered questionnaire

Subscribe